Peripheral arterial disease, also known as peripheral vascular disease is a condition in which the arteries, other than supplying blood to heart and brain narrow down. Peripheral arterial disease mostly affects the legs, though other arteries may also be involved. Peripheral arterial disease is caused by the deposition of fats (plaques) in the artery walls which reduce the blood flow to organs, limbs and head. The population over the age of 50 are at the risk of suffering from peripheral arterial disease. The growing geriatric population, increasing therapies, rising minimally invasive techniques support the growth for peripheral arterial disease market. It has been estimated that globally around 20% of the total population above the age of 60 years are affected by peripheral arterial diseases. High risk factors such as smoking and diabetes contributes towards increase in incidence rate of peripheral arterial diseases which would stimulate the growth of peripheral arterial disease market globally.
The peripheral arterial disease therapeutic market has been segmented into devices, drugs and pipeline. The devices segment is further categorized into devices such as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA Guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices and inferior vena cava filters. The peripheral vascular stents accounts for the largest share, followed by peripheral transluminal angioplasty balloon catheters. While emnolic protection devices are the fastest growing segment in the global peripheral arterial disease therapeutic market. The drugs segment can be segmented on the basis of cholesterol-lowering drugs, high blood pressure lowering drug, blood sugar regulating drug, and blood clot preventing drug. The phase III pipeline drugs for peripheral arterial disease include Rivaroxaban (Bayer), DLBS1033 (Dexa Medical Group), clopidogrel (SR25990) (Sonofi), Propionyl-L-Caritine (Sigma-Tau Research, Inc.) and others.
Geographically, peripheral arterial disease therapeutic market has been segmented in North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America, accounted for the largest share in the overall peripheral arterial disease therapeutic market. The dominance is majorly due the high adoption rates of minimally invasive surgeries, higher healthcare expenditure and patient awareness, making North America the leading market for peripheral arterial disease therapeutic market. Europe accounted for the second largest market for peripheral arterial disease therapeutic market. The aging population would boost the demand for peripheral arterial devices in the forecast period. Asia Pacific is anticipated to be the most lucrative market for peripheral arterial disease therapeutic market. The major factors attributing the fastest growth of this region is the presence of large patient pool with unmet medical needs, acting as the opportunity for the players operating in this market. Growing healthcare scenario in the Asian countries coupled with the growing GDP and government initiative would assist the market growth for peripheral arterial disease therapeutics market. South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to developing medical infrastructure, high disposable income and rising prevalence of peripheral arterial disease in the region assisting the market growth. The Rest of the World includes countries such as Russia and countries of Middle East and Africa. The market for peripheral arterial disease therapeutic is subject to grow due to the improving government initiative and rising awareness.
Some of the major players operating in the peripheral arterial disease therapeutics market are Abbott Laboratories, Angioscore, Inc., Edward Lifesciences Corporation, Medtronic Inc., Boston Scientific Corporation, Bayer, Volcano Corporation, Sanofi S.A. and others.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Middle East and Africa
- Latin America
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.